Author

Daniel Murillo

Observed names: D Murillo, D. Murillo, DANIEL MURILLO

Observed institutions: Louisiana State University, University of Kansas, The University of Kansas Health System, Research Medical Center, University of Kansas Medical Center, University of Nebraska Medical Center

ORCID: 0000-0002-6842-4446

Observed ORCID: 0000-0002-6842-4446

OpenAlex ID: A5070540325

Increased Access to Transplantation for Blood Group B Cadaveric Waiting List Candidates by Using A2 Kidneys: Time for a New National System?

2002 · Paul W Nelsona, Charles F Shield, et al. · American Journal of Transplantation · 56

PDF

Double Renal Transplants From Marginal Donors: 2-year Results

2000 · JOHN T. JERIUS, RODNEY J. TAYLOR, et al. · The Journal of Urology · 39

Improving Access to Kidney Transplantation without Decreasing Graft Survival: Long-Term Outcomes of Blood Group A2/A2B Deceased Donor Kidneys in B Recipients

2005 · Christopher F. Bryan, Franz T. Winklhofer, et al. · Transplantation · 37

Influence of Pill Burden and Drug Cost on Renal Function After Transplantation

2012 · Karen L. Hardinger, Timothy Hutcherson, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 32

Long-Term Survival of Kidneys Transplanted from Live A2 Donors to O and B Recipients

2007 · C.F. Bryan, P.W. Nelson, et al. · American Journal of Transplantation · 27

PDF

Adverse drug reaction driven immunosuppressive drug manipulations: a single‐center comparison of enteric‐coated mycophenolate sodium vs. mycophenolate mofetil

2008 · Karen L. Hardinger, Sudarshan Hebbar, et al. · Clinical Transplantation · 26

HLA Points Assigned in Cadaveric Kidney Allocation Should Be Revisited: An Analysis of HLA Class II Molecularly Typed Patients and Donors

2003 · Christopher F. Bryan, Kevin M. Harrell, et al. · American Journal of Transplantation · 25

PDF

Sharing kidneys across donor‐service area boundaries with sensitized candidates can be influenced by HLA C

2009 · Christopher F. Bryan, Alan M. Luger, et al. · Clinical Transplantation · 22

Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate.

2004 · Christopher F Bryan, Paul W Nelson, et al. · PubMed · 20

Renal graft survival is not influenced by a positive flow B‐cell crossmatch

2006 · Christopher F Bryan, Mark Wakefield, et al. · Clinical Transplantation · 19

The risk for Chagas' disease in the Midwestern United States organ donor population is low

2004 · Christopher F Bryan, Gary E Tegtmeier, et al. · Clinical Transplantation · 14

Successful renal transplantation despite low levels of donor‐specific HLA class I antibody without IVIg or plasmapheresis

2006 · Christopher F. Bryan, Scott B. McDonald, et al. · Clinical Transplantation · 13

Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates

2002 · Christopher F Bryan, Scott B McDonald, et al. · Clinical Transplantation · 9

Donor-specific antibodies present at the time of kidney transplantation in immunologically unmodified patients increase the risk of acute rejection

2016 · Aditi Gupta, Daniel Murillo, et al. · Transplant Immunology · 8

Bortezomib as rescue therapy for antibody mediated rejection: a single-center experience.

2010 · Karen L Hardinger, Kelly Alford, et al. · PubMed · 7

Bortezomib for acute humoral rejection in two repeat transplant recipients.

2009 · Karen L Hardinger, Kelly Alford, et al. · PubMed · 7

Point‐of‐care testing in an organ procurement organization donor management setting

2003 · K A Baier, L E Markham, et al. · Clinical Transplantation · 6

A New Role for the Virtual Crossmatch in Kidney Allograft Reuse

2010 · Christopher F. Bryan, Bashar Abdulkarim, et al. · Transplantation · 5

Double Renal Transplants From Marginal Donors:

2000 · JOHN T. JERIUS, RODNEY J. TAYLOR, et al. · The Journal of Urology · 3

Renal transplantation: surgical aspects, complications and results

1998 · Rodney J. Taylor, Daniel Murillo · Current Opinion in Urology · 3

The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.

2011 · Karen L Hardinger, Daniel Murillo · PubMed · 2

Characteristics of Renal Allograft Donors in the United Network for Organ Sharing Region 8.

2014 · K. Hardinger, S. Burton, et al. · Transplantation

Blood Group B Primary and Regraft Candidates Are Transplanted With A2/a2b Kidneys at the Same Rate Since a Isoagglutinins Remain Low

2008 · J L. Smith, C F. Bryan, et al. · Transplantation

75-P: IVIg reduces the risk of early vascular graft loss in patients with a remote positive HLA class I IgG donor-specific crossmatch

2007 · Christopher F. Bryan, Paul W. Nelson, et al. · Human Immunology

The 9-year survival of kidneys from blood group A2/A2B deceased donors is the same as that of B donors when transplanted into B patients

2004 · Christopher Bryan, Franz Winklhofer, et al. · Human Immunology

Works count: 26

Citation count: 380

H-index: 12

I10-index: 12